WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
5,20 THB
0,00%
(0,00) 1D
15. okt., 16:40:00 GMT +7 · THB
search
Vsi simboli
| Simbol | Cena | Sprememba | Odstotna sprememba |
|---|
insights_autoGeneriranje najpomembnejših vpogledov za WUXI06 …
Odpri
5,25 THB
Visoka
5,35 THB
Nizka
5,05 THB
Tržna kapitalizacija
200,24 mrd.
Povprečni promet
93,60 tis.
Promet
288,50 tis.
52-tedenski najvišji tečaj
6,25 THB
52-tedenski najnižji tečaj
3,02 THB
Št. izdanih delnic
4,12 mrd.
Št. zaposlenih
15 tis.
Odpri
5,25 THB
Visoka
5,35 THB
Nizka
5,05 THB
Tržna kapitalizacija
200,24 mrd.
Povprečni promet
93,60 tis.
Promet
288,50 tis.
52-tedenski najvišji tečaj
6,25 THB
52-tedenski najnižji tečaj
3,02 THB
Št. izdanih delnic
4,12 mrd.
Št. zaposlenih
15 tis.
Novice
Iz spletnih virov in novičarskih partnerjev
bloomingbit
·
pred 29 minutami
Nasdaq-Listed Tron Files $200 Million Stock Offering to Fund TRX Purchases
Hartford Business Journal
·
pred 25 minutami
Branford biotech Quantum-Si regains Nasdaq compliance as stock rebounds
ChartMill
·
pred 29 minutami
These S&P500 stocks are gapping in today's session
CNN
·
pred 4 urami
Global tech sell-off deepens as enthusiasm for AI stocks wobbles
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Vizitka: Wuxi Biologics (Cayman) Inc. KKPS DR
Generalni direktorZhisheng Chen
Št. zaposlenih14,7 tis.
Ustanovljeno2010
Sedež-
Sektor-
Spletno mestowuxibiologics.com